ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature

BACKGROUND: Although anaplastic lymphoma kinase (ALK) fusion genes are generally identified in lung adenocarcinoma patients, they are relatively rare in patients with squamous cell carcinoma (SqCC). Metastatic ALK-rearranged lung adenocarcinoma patients treated with ALK inhibitors demonstrate higher...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Mamesaya, Nobuaki, Nakashima, Kazuhisa, Naito, Tateaki, Nakajima, Takashi, Endo, Masahiro, Takahashi, Toshiaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501098/
https://ncbi.nlm.nih.gov/pubmed/28683775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3468-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak